•  
  •  
  •  
  •  

2025-12-23 14:20:57

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  SSPDL

Stock Report

  • SSPDL Ltd to exit from Godrej SSPDL Green Acres LLP
  • SSPDL Ltd posts consolidated loss of Rs. 1.86 crore in Q2 FY24
  • SSPDL Ltd consolidated Q4 FY2022-23 loss at Rs. 46.59 lakhs
  • SSPDL Ltd Q3 FY23 consolidated loss at Rs. 94.56 lakhs
  • SSPDL Ltd posts consolidated loss of Rs. 1.82 crore in Q1FY23
  • SSPDL posts Rs. 3.87 crore consolidated profit in Q4 FY2022
  • SSPDL Q3FY22 consolidated loss at Rs. 96.50 lakhs
  • SSPDL Ltd consolidated Q2FY22 loss at Rs. 1.94 crore
  • SSPDL Ltd announces resignation of Smt. Sridevi Challa

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024